GAYA Wellness

GAYA Wellness Call us today to learn more!
(1)

Gaya Wellness is a modern women’s health and weight loss and hormone balance clinic, offering expert OB/GYN-led virtual care with a compassionate, whole-body approach. From hormonal imbalances and PCOS to menopause, fertility, and medical weight loss programs with GLP-1, we help women reclaim their health with science-backed care that feels personal—not clinical. Led by Dr. Shweta Patel, a board-c

ertified and highly acclaimed OB/GYN, Gaya Wellness blends traditional gynecology with integrative medicine, delivering a virtual-first care model that caters to the time and convenience of today's busy women ( the way it should be!)

Offering Virtualcare in FL, VA, NC, IN, TN, and soon GA, SC, MD, NY and others!

I am a male patient and highly recommend Dr. Patel. I’ve lost 22 lbs in six months under her care. She is a knowledgeabl...
04/19/2026

I am a male patient and highly recommend Dr. Patel. I’ve lost 22 lbs in six months under her care. She is a knowledgeable professional and a supportive coach who gives you the tools you need to succeed. Thank you, Dr. Patel, for all your help!

A CNN investigation published in March documented a single po*******hywebsite receiving 62 million visits in one month —...
04/18/2026

A CNN investigation published in March documented a single po*******hy
website receiving 62 million visits in one month — hosting more than
20,000 videos of unconscious women, alongside Telegram groups where
men exchanged techniques for drugging their partners.

For women reading this, the implications go further than outrage.

Safety, in physiological terms, is not a feeling. It is a biochemical
state. Your hormonal system reads your environment constantly —
whether a boundary is respected, whether your no is heard, whether
your body is at any given hour a target. All of it registers. None
of it is metaphorical.

The Seattle Midlife Women's Health Study documented that 68% of
women in the late menopause transition show measurable cortisol
elevation. Sustained cortisol suppresses GnRH — the upstream signal
for estrogen, progesterone, and testosterone. Your two natural
brakes on the stress system, estradiol and progesterone, are
disappearing right when caregiving, career, and aging parents peak.

Medicine cannot make the world safe. It can restore the scaffolding
a woman's nervous system needs to regulate itself.

If what you have been told is "just hormones" has felt incomplete —
it is. Your body has been keeping the ledger. We read it with you.

Link in bio for the full piece and a real hormone panel.

For survivors: RAINN · 1-800-656-HOPE · 24/7 · rainn.org





The GLP-1 prescribing model has an addressable gap — and it sits at the intersection of obesity medicine and endocrinolo...
04/16/2026

The GLP-1 prescribing model has an addressable gap — and it sits at the intersection of obesity medicine and endocrinology.
Neither ATTAIN-1 nor SURMOUNT-1 stratified outcomes by menopausal status. The 12.4% mean weight loss on oral Foundayo and the 20.9% on injectable Zepbound were generated from populations that did not distinguish pre-, peri-, and postmenopausal women.
For a patient population where estrogen decline, progesterone shifts, cortisol dysregulation, and thyroid optimization are primary determinants of metabolic response, this is not a minor limitation.
The clinical question is not simply "oral or injectable." It is: what does this patient's hormonal environment predict about her GLP-1 response — and how do we optimize it before selecting a protocol?
At Gaya Wellness, our Weight Loss Concierge program maps the full hormonal picture before recommending any GLP-1 approach. Route of administration, dose titration, and adjunctive hormone optimization are all individualized.
The era of one-size-fits-all GLP-1 prescribing should be ending. Hormone-aware protocols are the next standard.

A GLP-1 weight loss pill just got FDA approved. Here's what you need to know.Foundayo (orforglipron) is Eli Lilly's once...
04/15/2026

A GLP-1 weight loss pill just got FDA approved. Here's what you need to know.
Foundayo (orforglipron) is Eli Lilly's once-daily oral GLP-1 — approved April 1, 2026.
It's the second pill in its class, after Rybelsus (oral semaglutide). But it works a little differently.
What GLP-1 medications do: → Mimic a hormone your body already makes → Slow digestion so you feel full longer → Improve insulin response → Reduce hunger and cravings
What makes Foundayo different: → Once-daily pill — no needles, no pen devices → Small molecule (not a peptide like semaglutide) → Same GLP-1 receptor activation as Ozempic, Wegovy, and Zepbound → Removes the injection barrier that kept millions from starting treatment
The injection barrier was real. For many women, it was the single reason they never started GLP-1 therapy.
A daily pill changes the access equation entirely.
But convenience and efficacy aren't the same thing — and you deserve to understand both before choosing.
📲 Full breakdown at the link in bio.
💬 Would a pill change whether you'd consider GLP-1? Tell me below.

Same drug. Same dose. Completely different results.One woman over 40 loses weight steadily on GLP-1. The other battles s...
04/14/2026

Same drug. Same dose. Completely different results.
One woman over 40 loses weight steadily on GLP-1. The other battles side effects and barely moves the scale.
The drug isn't broken. The hormonal environment is unmapped.
Four hormones shape how your body actually responds to GLP-1:
1️⃣ Estrogen — regulates insulin sensitivity and where your body stores fat 2️⃣ Progesterone — affects appetite and how your gut responds to satiety signals 3️⃣ Cortisol — drives fat storage and directly blunts GLP-1 receptor response 4️⃣ Thyroid — controls metabolic rate, the engine GLP-1 is working with
When these hormones are shifting — as they do in perimenopause and menopause — the body's response to GLP-1 changes. Appetite regulation, insulin sensitivity, fat distribution — all downstream of hormonal signaling.
GLP-1 doesn't fail. An unmapped hormonal environment does.
Optimize the hormonal environment first. Then the medication can do its job.
📲 Link in bio for the full science.
💬 Have you experienced unexpected GLP-1 results? Tell me below.

Zero.That's the number of major GLP-1 trials that separated results by menopausal status.Not ATTAIN-1. Not SURMOUNT-1. N...
04/13/2026

Zero.
That's the number of major GLP-1 trials that separated results by menopausal status.
Not ATTAIN-1. Not SURMOUNT-1. Not STEP.
The FDA just approved Foundayo — a GLP-1 pill — based on data that never asked whether participants were premenopausal, perimenopausal, or postmenopausal.
Why does that matter?
Because for women over 40, hormonal status is the single largest variable in weight loss response: → Estrogen decline slows metabolism independently of any drug → Perimenopause drives insulin resistance the trials never captured → Hormonal shifts redirect fat storage to the abdomen through a completely separate mechanism
That 12.4% weight loss headline? It may significantly overstate — or understate — what a woman in hormonal transition will actually experience.
This isn't a footnote. It's a structural blind spot.
Millions of women are making treatment decisions based on data that was never designed to answer their question.
📲 Full breakdown at the link in bio.
💬 Did your doctor discuss your menopausal status before prescribing GLP-1? Tell me below.

The FDA just approved Foundayo — a once-daily GLP-1 pill for weight loss.Convenience? Absolutely. But the numbers tell a...
04/12/2026

The FDA just approved Foundayo — a once-daily GLP-1 pill for weight loss.
Convenience? Absolutely. But the numbers tell a more complicated story.
In clinical trials: → Foundayo pill: 12.4% body weight lost → Zepbound injection: 20.9% body weight lost Same 72-week timeframe. Same class of drug.
That 8.5-point gap? On a 200-pound woman, it's 17 pounds.
Does that mean the pill is wrong for everyone? No. Needle aversion is real. Travel logistics are real. And adherence beats peak efficacy every time.
But you deserve to make that decision with the actual data — not the headline.
The most effective GLP-1 is the one you'll stick with. But you should know what you're choosing between.
📲 Link in bio for the full breakdown.
💬 Pill or injection — what matters most to you? Drop it below.

876,805 women. 14 years of follow-up. The largest study of its kind.The result? HRT was NOT associated with increased mo...
04/08/2026

876,805 women. 14 years of follow-up. The largest study of its kind.

The result? HRT was NOT associated with increased mortality. No difference in cardiovascular death. No difference in cancer death. Not even after a decade of use.

This is the 2026 BMJ Danish cohort study — and it confirms what the data has been saying for years: HRT started near menopause doesn't shorten your life. Avoiding it might.

When you start HRT within 10 years of menopause, the evidence shows:
→ 30% reduction in all-cause mortality
→ 48% fewer fatal cardiac events
→ 34% fewer hip fractures

And yet — an entire generation of women was scared away from treatment by the 2002 WHI study. The problem? The average WHI participant was 63. Over 90% were past 55. Women with hot flashes were literally excluded.

That's like testing blood pressure medication on people with advanced heart disease and telling healthy people not to take it.

In November 2025, the FDA removed the black box warning from HRT. The science won. But the fear is still out there.

Untreated menopause accelerates heart disease, causes up to 20% bone loss, drives insulin resistance, and shrinks grey matter in memory-critical brain regions. The real risk isn't HRT. It's doing nothing.

Your second half deserves a strategy.

🔗 Link in bio → gayawellness.com/her-longevity
🔬 Book a discovery call: gayawellness.com/her-longevity

Your metabolism didn't break. Your hormones shifted.That's the conversation nobody has with you during perimenopause. In...
04/06/2026

Your metabolism didn't break. Your hormones shifted.

That's the conversation nobody has with you during perimenopause. Instead you hear "eat less, move more" while your body is rewriting its entire metabolic playbook.

Here's what's actually happening:

→ Estrogen drops → your cells stop responding to insulin efficiently
→ Fat storage shifts to your midsection — regardless of what you eat
→ Lean muscle declines, which tanks your metabolic rate
→ LDL cholesterol creeps up
→ Thyroid function slows everything down further

40% of women develop insulin resistance during perimenopause. And calorie counting won't fix an insulin problem. You need to know your numbers: fasting blood sugar, HbA1c, lipid panel, fasting insulin, thyroid panel. Then you need a protocol built around YOUR biology.

That's what Hormonal Agency™ does. Board-certified OB/GYN. Quarterly labs included. Testosterone prescribed. Three tiers from $149/mo.

You're not broken. Your approach just hasn't caught up to your biology.

🔗 Link in bio → gayawellness.com/hormonal-agency
💊 Use code HORMONESFIRST for $50 off your first month

28.7% body weight loss. Roughly 71 pounds. In one Phase 3 trial.Retatrutide isn't another GLP-1. It's a triple receptor ...
04/04/2026

28.7% body weight loss. Roughly 71 pounds. In one Phase 3 trial.

Retatrutide isn't another GLP-1. It's a triple receptor agonist — targeting GLP-1, GIP, AND glucagon simultaneously. That third receptor? It tells your body to burn stored fat for fuel. Not just eat less. Metabolize more.

And it hasn't even hit a weight loss plateau at 68 weeks.

So why am I writing about a drug you can't get yet?

Because right now — before retatrutide even has an FDA approval date — Eli Lilly and Novo Nordisk are spending millions to dismantle the compounding pharmacy ecosystem that could make it affordable when it finally arrives.

Brand-name Wegovy: $1,349/month.
Compounded GLP-1: $200–$400/month.
Ingredient cost to manufacture: under $5.

The crackdown isn't about safety. It's about margin.

And women over 40 — the population that needs these medications most — are caught in the crossfire.

You don't have to wait until 2028. Our Weight Loss Concierge program gives you physician-managed GLP-1 therapy starting at $149/mo. 50+ biomarker panel. Board-certified OB/GYN. Real medical oversight — not an algorithm.

Your body changed. The science finally caught up. Don't let the system price you out of the solution.

🔗 Link in bio → gayawellness.com/weight-loss-concierge
💊 Use code METABOLISM20 for $50 off your first month

Is your metabolism staging a coup after 40? 🤔  Let’s stop letting outdated stories dictate how we feel in our skin. If y...
04/01/2026

Is your metabolism staging a coup after 40? 🤔
Let’s stop letting outdated stories dictate how we feel in our skin. If you’ve been feeling sluggish, noticing those pesky weight shifts, or think you just have to “ride this out,” it’s time to change the narrative. Your metabolism isn’t a lost cause; it’s a call to action just waiting for you to respond. Together, we can redefine what thriving in midlife means. Ready to challenge the status quo? Share your metabolism struggles below, and let’s spark a movement that empowers women to take back their metabolic mojo! 💪🔥

👉 Join our community to uncover tips for optimizing your wellness and mastering your metabolism!

, , , , , , ,

Address

-
Winter Garden, FL
34787

Opening Hours

Monday 10am - 4pm
Tuesday 10am - 4pm
Wednesday 10am - 4pm
Thursday 10am - 4pm
Friday 10am - 1pm

Alerts

Be the first to know and let us send you an email when GAYA Wellness posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to GAYA Wellness:

Share